Managers / Q2 2020 · view latest →
EADS & HEALD WEALTH MANAGEMENT
CIK 0001035912 · SUITE 760, 2100 RIVEREDGE PKWY NW, ATLANTA, GA, 30328 · (770)988-9556
Summary
Eads & Heald Wealth Management reported $165M in U.S.-listed holdings across 120 positions for Q2 2020.
Its largest position, AMZN, represents 2.2% of the portfolio.
Compared with Q1 2020, the fund opened 6 new positions and exited 4.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 85.5% · $141M
- Other · 13.9% · $23M
- NY Reg Shrs · 0.3% · $513,000
- ADR · 0.3% · $430,000
Quarter-over-Quarter Changes full breakdown →
vs Q1 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| Raytheon Technologies | NEW | +12.1K | 12.1K | +$743,000 | $743,000 |
| AbbVie | NEW | +3.5K | 3.5K | +$341,000 | $341,000 |
| Netflix | NEW | +657 | 657 | +$299,000 | $299,000 |
| FITBFifth Third Bancorp | NEW | +15.5K | 15.5K | +$299,000 | $299,000 |
| ITT Corporation | NEW | +4.1K | 4.1K | +$243,000 | $243,000 |
| Quest Diagnostics | NEW | +2.1K | 2.1K | +$234,000 | $234,000 |
| EWEdwards Lifesciences | ADDED | +20.4K | 30.5K | +$189,000 | $2M |
| Merck | ADDED | +7.3K | 13.2K | +$571,000 | $1M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2020
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $201M | 140 | Apr 29, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | Under review | 141 | Jan 29, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $209,468 | 139 | Oct 22, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $202,397 | 134 | Jul 22, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $196,869 | 138 | Apr 25, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $203,255 | 135 | Jan 17, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $211,080 | 144 | Oct 28, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $206,986 | 144 | Jul 23, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $214,444 | 144 | Apr 23, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $207,788 | 145 | Jan 30, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $190,643 | 142 | Oct 27, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $203,399 | 145 | Jul 25, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $201,876 | 144 | Apr 21, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 145 | Jan 27, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $176M | 143 | Oct 27, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $186M | 148 | Jul 26, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $216M | 147 | Apr 27, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $230M | 146 | Jan 31, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $207M | 142 | Oct 27, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $205M | 137 | Jul 30, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $195M | 137 | Apr 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $186M | 132 | Feb 2, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $167M | 125 | Nov 2, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $165M | 120 | Jul 29, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $141M | 118 | May 1, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $189M | 129 | Jan 31, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $179M | 129 | Oct 31, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $177M | 126 | Jul 30, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $173M | 126 | Apr 26, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $150M | 124 | Jan 31, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.